Thermo Fisher Scientific received a Buy rating from Wells Fargo and an amendment to its agreement with SOLVE was announced.
1 report, 0 independent
Updated Jun 30
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Thermo Fisher Scientific received a Buy rating from Wells Fargo and an amendment to its agreement with SOLVE was announced.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Thermo Fisher Scientific Inc.
multinational company providing scientific instrumentation
Nothing else this week.
-
SOLVE
American environmental organization
Nothing else this week.
-
Wells Fargo
American multinational banking and financial services company
Related events
- Thermo Fisher Scientific Inc. and iSpecimen are two healthcare companies that are currently competing for market share.
- Thermo Fisher Scientific Inc. filed required reports with the SEC on June 16, 2026, influenced by analyst reports from Morgan Stanley.
- HSBC raised its rating to strong-buy and Morgan Stanley raised its target price for Thermo Fisher Scientific Inc.
Coverage
Newest first; wire copies grouped- Unknown outlet